5 completed, 2 terminated, 1 active not recruiting, 1 not yet recruiting. 11 Phase 1, 7 Phase 2.
Follow Sarcoidosis: new trials by email Literature Review of Sarcoidosis trials Research Report on Sarcoidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FAPI PET Imaging - An Exploratory Study [18F]FAPI-74 PET/CT - Thyroid Pathology, Head and Neck Cancer (H&N) | Phase 1 / Phase 2 | Not yet recruiting | Martin Huellner | 770 | 2026-08-01 | 2026-07-15 |
| Feasibility of Semaglutide in Advanced Lung Disease Semaglutide Pen Injector - Obesity, Interstitial Lung Disease | Phase 1 / Phase 2 | Recruiting | University of Pennsylvania | 8 | 2024-01-29 | 2026-04-21 |
| Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations XTMAB-16 or Placebo - Pulmonary Sarcoidosis | Phase 1 / Phase 2 | Active not recruiting | Xentria, Inc. | 32 | 2023-11-10 | 2026-10-02 |
| Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. [64]Cu Macrin - Sarcoid, Cardiovascular Diseases | Phase 1 | Unknown | Ralph Weissleder, MD | 100 | 2021-09-06 | 2022-06-23 |
| Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial, Spirometry, RNA Sequencing - Sarcoidosis, Pulmonary, Sarcoidosis Lung | Phase 1 | Completed | Oregon Health and Science University | 5 | 2019-05-15 | 2022-02-18 |
| Study of Intravenous ATYR1923 (Efzofitimod) for Pulmonary Sarcoidosis Efzofitimod 1.0 mg/kg or Placebo, Efzofitimod 3.0 mg/kg or Placebo, Efzofitimod 5.0 mg/kg or Placebo - Pulmonary Sarcoidosis | Phase 1 / Phase 2 | Completed | aTyr Pharma, Inc. | 37 | 2019-01-29 | 2023-07-18 |
| Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study Habitrol, Placebo to Habitrol - Sarcoidosis | Phase 1 / Phase 2 | Completed | Ohio State University | 50 | 2015-10-21 | 2025-04-24 |
| Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis PDA001 (cenplacel-L) - Stage 2 Pulmonary Sarcoidosis, Stage 3 Pulmonary Sarcoidosis | Phase 1 | Terminated | Celularity Incorporated | 4 | 2011-09-01 | 2018-03-01 |
| Investigation of the Efficacy of Antibiotics on Pulmonary Sarcoidosis levaquin; ethambutol; rifampin and azithromycin. - Pulmonary Sarcoidosis, Lung Function | Phase 1 | Completed | Vanderbilt University | 15 | 2010-07-01 | 2012-10-31 |
| Trial of Antimycobacterial Therapy in Sarcoidosis Antibiotic Regimen, Placebo Regimen - Sarcoidosis | Phase 1 / Phase 2 | Completed | Vanderbilt University | 30 | 2010-02-01 | 2016-12-12 |
| Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis Autologous hematopoietic stem cell transplantation, Allogeneic stem cell transplantation - Sarcoidosis | Phase 1 / Phase 2 | Terminated | Northwestern University | 2 | 2003-12-01 | 2018-08-31 |
Sarcoidosis, Pulmonary (6) · Lung Diseases, Interstitial (2) · Mycobacterium Infections (2) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Transitional Cell (1) · Cardiovascular Diseases (1) · Disease (1) · Endometriosis (1) · Granuloma (1) · Head and Neck Neoplasms (1) · Hypertension, Pulmonary (1) · Inflammation (1) · Liver Cirrhosis (1)
Hemic and Lymphatic Diseases (11) · Hypersensitivity (11) · Hypersensitivity, Delayed (11) · Immune System Diseases (11) · Lymphatic Diseases (11) · Lymphoproliferative Disorders (10) · Lung Diseases (7) · Respiratory Tract Diseases (7) · Lung Diseases, Interstitial (5) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Actinomycetales Infections (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Cardiovascular Diseases (2)
Azithromycin (2) · Ethambutol (2) · Levofloxacin (2) · Rifampin (2) · Adrenal Cortex Hormones (1) · Clinical Laboratory Techniques (1) · Clinical Trials as Topic (1) · Nicotine (1) · Respiratory Function Tests (1) · Sequence Analysis, RNA (1) · Spirometry (1) · Tablets (1) · semaglutide (1) · tofacitinib (1)
Vanderbilt University (2) · Celularity Incorporated (1) · Martin Huellner (1) · Northwestern University (1) · Ohio State University (1) · Oregon Health and Science University (1) · Ralph Weissleder, MD (1) · University of Pennsylvania (1) · Xentria, Inc. (1) · aTyr Pharma, Inc. (1)
United States (10) · Czechia (1) · Denmark (1) · Poland (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Wonder P Drake, MD (2) · Gennyne Walker (1) · Jim Rosenbaum, MD (1) · Michaela R Anderson, MD (1) · Monica E Luchi, MD (1) · Richard Burt, MD (1)
PMID 23863960, PMID 24284293, PMID 33089005, PMID 33825964, PMID 34029565, PMID 36356657, PMID 37854715, PMID 41469153